Galmed Pharmaceuticals (GLMD) PT Raised to $14 at Maxim Group
Tweet Send to a Friend
Maxim Group raised its price target on Galmed Pharmaceuticals (NASDAQ: GLMD) to $14.00 (from $9.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
